Skip to main content

Table 3 Summary of migraine outcomes at follow-up*

From: The effect of 1 mg folic acid supplementation on clinical outcomes in female migraine with aura patients

Analyte

Placebo (n = 63)

1 mg (n = 126)

P value*

(a) High Disability

34 (52 %)

56 (45 %)

0.4

(b) High Frequency

28 (43 %)

44 (36 %)

0.33

(c) High Severity

12 (19 %)

16 (13 %)

0.31

  1. Values are n (%)
  2. High disability (a) is defined as a MIDAS score >11, High Frequency (b) is defined as a score >10 (median) and High Severity (c) is defined as a score >7 (median). All scores were categorised due to the deviation from non-normal distribution and to improve interpretation
  3. *P value were determined by Chi-square tests
Back to article page

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us